Last April, the Sewree TB Hospital started the Directly Observed Treatment Short-course (DOTS)-Plus initiative for patients detected with multi-drug resistant tuberculosis (MDR-TB), wherein patients are resistant to at least two of the best anti-TB drugs prescribed in the first line of treatment. These patients are usually admitted for a week to check if the patient had an adverse reaction of the drug administered and to ensure compliance.
Of the 276 patients admitted since April, 20 died. Seventeen patients did not come to the hospital for a follow-up.
Of the total of 44 DOTS-plus beds available in the hospital, 15 were occupied this month.
One 55-year-old patient was detected with extensively drug-resistant tuberculosis (XDR-TB), where the patient is resistant to the most effective anti-TB drugs. “I have been suffering from TB for around two years. I got TB after my wife died of the same disease four years ago,” said a XDR-TB patient, who requested anonymity. The patient, a former mill worker from Wadala, has been admitted to Sewree hospital for the third time in the past two years.
Last year, the National Institute of Tuberculosis, Bangalore, confirmed that one of the patients who died was suffering from XDR-TB.
More than 100 chemists to attend TB workshops
On Saturday and Sunday, more than 100 chemists will participate in training programmes for tuberculosis awareness in two separate workshops at Mulund and Ulhasnagar.
These workshops are held as part of an awareness initiative run by the BMC and the Indian Pharmaceutical Association (IPA).
In the past year, the initiative involved 150 chemists from Bhiwandi, Kalyan and Dombivli. They were trained to provide government’s TB DOTS (Directly Observed TB Short Course) medicines and patient identification.
The IPA plans to train at least 500 retail pharmacists by next year. HTC